NOMW Health are building LifeSavr, an innovative wearable device aimed at addressing the opioid overdose crisis. LifeSavr uses advanced sensor technology for real-time detection of opioid overdoses. Problem Image The global prevalence of opioid overdose has become a significant concern. In 2021, about 60 million people worldwide used opioids and there were 1,330 drug-related deaths recorded in Scotland alone with the number of fatalities predicted to more than double by 2025. However, overdose deaths are preventable if detected early and there is timely administration of naloxone, an antidote that reverses opioid effects. Solution We have developed a wearable device that monitors vital signs to detect opioid overdoses, alerting users, emergency services, and contacts. This device uses multimodal sensors for high accuracy and aims to employ AI to identify high-risk users and manage data. Additionally, a server-side application has been built, allowing charities to monitor devices, manage emergencies, and maintain user data, enabling timely Naloxone administration to save lives. Market LifeSavr addresses the $631 billion opioid crisis, with healthcare device market projected to grow at a CAGR of 15.51% from 2024-2028, offering a conducive market for LifeSavr. Contact NOMW Health website NOMW Health LinkedIn This article was published on 2024-09-30
